| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $486.8M | +70.9% |
| Cost of Revenue | $193.5M | +80.4% |
| Gross Profit | $293.3M | +65.1% |
| R&D Expense | $10.8M | -5.1% |
| SG&A Expense | $83.1M | +5.1% |
| Operating Income | -$1.03B | -761.3% |
| Pre-tax Income | -$1.04B | -705.1% |
| Income Tax | -$33.4M | -166.6% |
| Net Income | -$1.01B |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $40.6M | -85.3% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $83.8M | +6.0% |
| Current Assets | $155.4M | -65.9% |
| Total Assets | $937.3M | -58.6% |
| Current Liabilities | $126.6M | -76.3% |
| Total Liabilities | $342.7M | -50.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $16.3M | +125.2% |
| Capital Expenditures | $387K | -7.9% |
| Investing Cash Flow | $58.1M | +173.2% |
| Financing Cash Flow | -$311.0M | -175.9% |
| Free Cash Flow | $15.9M | +124.4% |
| -762.8% |
| EPS (Basic) | -$14.06 | -430.6% |
| EPS (Diluted) | -$14.06 | -430.6% |
| Stockholders' Equity |
| $594.6M |
| -62.2% |